Indian-American CEO to pay up to $50 mn to settle claims of underpaying Medicaid rebates
A pharmaceutical company in the US and its Indian-origin chief have agreed to resolve allegations that they knowingly underpaid Medicaid rebates due for the company's drug Nitrofurantoin Oral Suspension (Nitro OS).